# Panel and Database

> [**PDFs**](https://cloud.tsinghua.edu.cn/d/07d2b19d6b284ebea5ea/?p=%2F1.%20Precision%20Medicine\&mode=list)

## 0. Databases

* **2024 NAR** - cfOmics: a cell-free multi-Omics database for diseases
* _**2021 NAR**_ - exoRBase 2.0: an atlas of mRNA, lncRNA and circRNA in extracellular vesicles from human bioﬂuids
* _**2020 NAR**_ - Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles
* _**2020 NAR**_ - CFEA a cell-free epigenome atlas in human disease
* _**2019 NAR**_ - BBCancer: an expression atlas of blood-based biomarkers in the early diagnosis of cancers

## I. NGS Analysis

### **RNA-seq Analysis - Differential Expression**

* _**2021 Theranostics**_ - Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer
* **circRNA**: _2020 PLOS Comp. Bio._ - seekCRIT: Detecting and characterizing differentially expressed circular RNAs using high-throughput sequencing data

### **RNA-seq Analysis - More**

* see more RNA-seq analysis pipelines in [Tutorial: RNA Regulation Analysis](https://lulab2.gitbook.io/teaching/part-iii.-ngs-data-analyses/6.rna-regulation-analyses)

## **II. Meta-Analysis**

* \[Protein markers] _**2016 Lancet Neurol**_ - CSF and blood biomarkers for the diagnosis of Alzheimer's disease- a systematic review and meta-analysis
* \[DNA markers] _**2014 Nat Genetics**_ - Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk
* \[lncRNA markers] _**2005 Cancer Res.**_ - Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis
* \[Practical Review] _**2015 Korean J Radiol**_ Systematic Review and Meta-Analysis of Studies Evaluating Diagnostic Test Accuracy: A Practical Review for Clinical Researchers
  * Part I. General Guidance and Tips
  * Part II. Statistical Methods of Meta-Analysis

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FBiomarker%20Panel%2FMeta-analysis\&mode=list)

## III. Large-cohort Validation/Screen

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FBiomarker%20Panel%2FLarge-cohort%20Validation\&mode=list)

### cfRNA Panels

* 2022 Mol Cancer - A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study
* **✨ miRNA panel:&#x20;**_**2022 Mol Cancer -**_ A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study
* **✨ circRNA  panel:&#x20;**_**2022 Mol Cancer -**_ Diagnostic efcacy of circular RNAs as noninvasive liquid biopsy biomarkers for early detection of gastric cancer
* **✨ mRNA panel:&#x20;**_**2021 Mol Cancer -**_ Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer
* **lncRNAs+miRNAs**_**: 2021 Theranostics**_ -Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer
* **miRNAs:** _**2020 Gut**_ - Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
* **miRNAs:** _**2020 PNAS**_ - Development of a serum miRNA panel for detection of early stage non-small cell lung cancer
* **✨ small exosomal RNA:** _**2019 Molecular Cancer**_ - Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
* **✨ miRNA7**: _**2011 JCO**_ - Jia Fan - Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma

### Other Detection/Diagnosis Panels

* ✅ (neoadjuvant biomarker) [_**2022 Mol. Cancer**_ ](https://doi.org/10.1186/s12943-022-01684-9)- A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer
* ✅ (SLE biomarker) [_**2022 Lancet Rheumatol**_](https://www.sciencedirect.com/science/article/pii/S2665991322003320?via%3Dihub) - Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial
* **ctDNA+Protein (CancerSEEK)**: 2018 - Science - Detection and localization of surgically resectable cancers with a multi-analyte blood test
  * 2019 - iScience - Early Cancer Detection from Multianalyte Blood Test Results
  * 2021 - Bioinformatics - CancerEMC frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA
* **ctDNA+Protein+Clinical Info**: 2019 - PNAS - Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy

### Other Prognosis Panels

* **Progosis ctDNA**: 2019 JCO - Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
* **Prognosis ctDNA**: 2019 JAMA Oncology - Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
* **Prognosis ctDNA**: 2019 Translational Med. - Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
* **Prognosis ctDNA**：2019 JAMA Oncology - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
* **Liquid vs. tissue biopsy**： 2019 Nature Medicine - Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
